INVO BIOSCIENCE

invo-bioscience-logo

INVO Bioscience is a medical device company founded by Claude Ranoux, MD, MS, a noted expert in the field of reproductive health, infertility and embryology. Dr. Ranoux developed the INVO Procedure, the process of using intra-vaginal culture (IVC) and the INVOcellโ„ข, a novel biological capsule, for oocyte (egg) fertilization and early-stage embryo development in the womanโ€™s vaginal cavity.

#SimilarOrganizations #People #Financial #Event #Website #More

INVO BIOSCIENCE

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
2008-01-01

Address:
Medford, Massachusetts, United States

Country:
United States

Website Url:
http://www.invobioscience.com

Total Employee:
1+

Status:
Active

Contact:
978-878-9505

Email Addresses:
[email protected]

Total Funding:
4.85 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

blue-belt-technologies-logo

Blue Belt Technologies

Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.

impel-neuropharma-logo

Impel NeuroPharma

Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.

senseonics-logo

Senseonics

Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.

the-cooper-companies-logo

The Cooper Companies

The Cooper Companies, Inc. (Cooper) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO).

Current Employees Featured

andrea-goren_image

Andrea Goren
Andrea Goren CFO @ Invo Bioscience
CFO
2021-06-01

david-n-baker_image

David N. Baker
David N. Baker Advisior @ Invo Bioscience
Advisior
2020-01-01

not_available_image

Steven Shum
Steven Shum Chief Executive Officer @ Invo Bioscience
Chief Executive Officer
2019-10-01

not_available_image

Robert J. Bowdring
Robert J. Bowdring Director @ Invo Bioscience
Director

not_available_image

Barbara Levy
Barbara Levy Senior VP, Global Clinical Integration @ Invo Bioscience
Senior VP, Global Clinical Integration
2021-07-01

steven-m-shum_image

Steven M. Shum
Steven M. Shum CEO @ Invo Bioscience
CEO
2019-10-01

not_available_image

Claude Ranoux
Claude Ranoux Founder, President and Chief Scientist Officer @ Invo Bioscience
Founder, President and Chief Scientist Officer

inger-britt-carlsson_image

Inger Britt Carlsson
Inger Britt Carlsson Vice President of Global Medical Affairs @ Invo Bioscience
Vice President of Global Medical Affairs
2020-01-01

Founder


not_available_image

Claude Ranoux

Stock Details


Company's stock symbol is NASDAQ:IVOB

Investors List

daniel-schryer_image

Daniel Schryer

Daniel Schryer investment in Convertible Note - Invo Bioscience

daniel-schryer_image

Daniel Schryer

Daniel Schryer investment in Post-IPO Debt - Invo Bioscience

Official Site Inspections

http://www.invobioscience.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K

  • Host name: 104.21.47.47
  • IP address: 104.21.47.47
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Invo Bioscience"

Invo Bioscience - Crunchbase Company Profile & Funding

Organization. Invo Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; โ€ฆSee details»

INVOBioscience - Org Chart, Teams, Culture & Jobs | The Org

View INVOBioscience's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

INVO Bioscience - LinkedIn

INVO Bioscience | 1,263 followers on LinkedIn. Life Begins Within | At INVO bioscience, we are democratizing fertility. Our mission is to help people realize the dream of parenthood by increasing ...See details»

ABOUT US - INVO Bioscience

The INVOcell story . INVO Bioscience is dedicated to making fertility care accessible and inclusive to people around the world. Our flagship product is INVOcell, a revolutionary reproductive โ€ฆSee details»

THE TEAM - INVO Bioscience

April McGhee VP of Clinical Operations. April joined INVO Bioscience in September of 2022. April has over 20 year of experience in the medical...See details»

INVO Bioscience - Craft

Oct 29, 2024 INVO Bioscience $3.02 m in annual revenue in FY 2023. See insights on INVO Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Invo Bioscience - businessabc.net

Feb 25, 2025 Invo Bioscience was founded in 2012 to address the unmet need of making in-vivo Intra-Cytoplasmic Sperm Injection (ICSI) more accessible and affordable, while preserving the โ€ฆSee details»

INVO Bioscience - Company Profile - Tracxn

Jan 11, 2025 INVO Bioscience - Biological device for intravaginal culture and fertilization. Public Company. Raised funding over 6 rounds from 1 investor. Founded by Claude Ranoux in the โ€ฆSee details»

Invo Bioscience - PitchBook

Invo Bioscience General Information Description. NAYA Biosciences operates a healthcare services fertility business as well as expand its focus to the development of first-in-class โ€ฆSee details»

INVO Bioscience Launches New Corporate Website - PR Newswire

Oct 4, 2016 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcellโ„ข,...See details»

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy ...

Jan 17, 2024 INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced, entrepreneurial leadership team to โ€ฆSee details»

Invo Bioscience - Overview, News & Similar companies - ZoomInfo

Popular Searches INVO Bioscience INVO BioScience Inc Bioscience Inc INVOBioscience Biosciences SIC Code 87,873 NAICS Code 54,541 Ticker OTC: INVO Show more. Similar โ€ฆSee details»

Francisco Arredondo MD, MPH, FACOG โ€“ INVO Bioscience®

His determination to become a fertility specialist led him to do: research at the World Health Organizationโ€™s Reproductive Biology Center in Mexico City; an internship in Kahn Mount Sinai โ€ฆSee details»

INVOBioscience - Facebook

INVOBioscience, South Sarasota, Florida. 374 likes. Life Begins Within. We are a commercial-stage fertility company expanding access to advanced treatment worldwide.See details»

Matthew Szot - Chief Financial Officer - Cadrenal ... - LinkedIn

Chief Financial Officer at Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) - advancing its late-stage drug candidate tecarfarin, a new blood thinner for patients with implanted cardiac devices and โ€ฆSee details»

INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA

BEVERLY, Mass., Jan. 20, 2012 /PRNewswire/ -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, โ€ฆSee details»

INVO Bioscience Investors - Facebook

INVO Bioscience Investors. 154 likes. This is a community page for INVO Bioscience current and future investors. Here we can share informaSee details»

Michael J. Campbell โ€“ INVO Bioscience®

Michael J. Campbell COO and VP, Business Development. Mike joined INVO Bioscience as COO and VP of Business Development in 2019. He was most recently the Vice President of IVF โ€ฆSee details»

Establishing Canadaโ€™s first large-scale bioinnovation centre

3 days ago Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth โ€“ Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to โ€ฆSee details»

J. Chris Jensen โ€“ INVO Bioscience®

J. Chris Jensen VP of Engineering, Quality and Regulatory Affairs. Chris joined INVO Bioscience in 2020 as the Vice President of Quality and Regulatory Affairs.See details»

linkstock.net © 2022. All rights reserved